TJP2 Antikörper (AA 1165-1183)
Kurzübersicht für TJP2 Antikörper (AA 1165-1183) (ABIN7140173)
Target
Alle TJP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1165-1183
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Peptide sequence from Human Tight junction protein ZO-2 protein (1165-1183AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:500-1:1000, IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TJP2 (Tight Junction Protein 2 (Zona Occludens 2) (TJP2))
-
Andere Bezeichnung
- TJP2
-
Hintergrund
-
Background: Plays a role in tight junctions and adherens junctions.
Aliases: C9DUPq21.11 antibody, DFNA51 antibody, DUP9q21.11 antibody, Friedreich ataxia region gene X104 (tight junction protein ZO-2) antibody, MGC26306 antibody, PFIC4 antibody, Tight junction protein 2 antibody, Tight junction protein ZO 2 antibody, Tight junction protein ZO-2 antibody, TJP2 antibody, X104 antibody, ZO 2 antibody, ZO-2 antibody, ZO2 antibody, ZO2_HUMAN antibody, Zona occludens 2 antibody, Zona occludens protein 2 antibody, Zonula occludens protein 2 antibody
-
UniProt
- Q9UDY2
Target
-